1.Restorative therapy using autologous bone marrow derived mononuclear cells infusion intra-arterially in patients with cerebral palsy: An open label feasibility study
MV Padma Srivastava ; A Bhasin ; S Mohanty ; S Sharma ; U Kiran ; CS Bal ; S Gaikwad ; MB Singh ; R Bhatia ; M Tripathi ; K Prasad ; S Singh ; V Goyal ; G Shukla ; M Behari
Neurology Asia 2011;16(3):231-239
Cerebral Palsy is a common and devastating neurological disorder, with no medical treatment apart
from physiotherapy regimes to alleviate the functional disability. Regenerative medicine using stem
cells has gained momentum in recent years as a possible strategy to repair the injured brain. Present
study was undertaken in a open label series to evaluate the safety, feasibility and observe for any
benefi cial effects of intra-arterial infusion of autologous bone marrow derived mononuclear cells in
patients with cerebral palsy with moderate disability. Functional improvement was assessed using
the motor power and spasticity scales, dystonia and abnormal movements scale and the activities of
daily living scales by modifi ed Barthel Index and modifi ed Rankin Scores. Serial structural imaging
with MRI and functional imaging with FDG-PET scans were done. Of the 30 patients injected with
an average of 10-30 million cells into each carotid artery, improvements were observed in all clinical
scales, and predominantly in the disability scores. No adverse events were noted on a 12 months
follow up.
2.Transfer Dysphagia Due to Focal Dystonia
Priyanka SAMAL ; Vinay GOYAL ; Govind K MAKHARIA ; Chandan J DAS ; Sankar Prasad GORTHI ; Vishnu VY ; Mamta Bhushan SINGH ; M V Padma SRIVASTAVA
Journal of Movement Disorders 2018;11(3):129-132
OBJECTIVE: The inability to propel a bolus of food successfully from the posterior part of the oral cavity to the oropharynx is defined as transfer dysphagia. The present case series describes the varied presentation of transfer dysphagia due to focal dystonia and highlights the importance of early detection by following up on strong suspicions. METHODS: We describe seven cases of transfer dysphagia due to focal dystonia. Transfer dysphagia as a form of focal dystonia may appear as the sole presenting complaint or may present with other forms of focal dystonia. RESULTS: Four out of seven patients had pure transfer dysphagia and had previously been treated for functional dysphagia. A high index of suspicion, barium swallow including videofluoroscopy, associated dystonia in other parts of the body and response to drug therapy with trihexyphenidyl/tetrabenazine helped to confirm the diagnosis. CONCLUSION: Awareness of these clinical presentations among neurologists and non-neurologists can facilitate an early diagnosis and prevent unnecessary investigations.
Barium
;
Deglutition Disorders
;
Diagnosis
;
Drug Therapy
;
Dystonia
;
Dystonic Disorders
;
Early Diagnosis
;
Humans
;
Mouth
;
Oropharynx
3.Association of Elevated Blood Pressure Levels with Outcomes in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis: A Systematic Review and Meta-Analysis
Konark MALHOTRA ; Niaz AHMED ; Angeliki FILIPPATOU ; Aristeidis H KATSANOS ; Nitin GOYAL ; Konstantinos TSIOUFIS ; Efstathios MANIOS ; Maria PIKILIDOU ; Peter D SCHELLINGER ; Anne W ALEXANDROV ; Andrei V ALEXANDROV ; Georgios TSIVGOULIS
Journal of Stroke 2019;21(1):78-90
BACKGROUND AND PURPOSE: Although arbitrary blood pressure (BP) thresholds exist for acute ischemic stroke (AIS) patients eligible for intravenous thrombolysis (IVT), current international recommendations lack clarity on the impact of mean pre- and post-IVT BP levels on clinical outcomes. METHODS: Eligible studies involving IVT-treated AIS patients were identified that reported the association of mean systolic BP (SBP) or diastolic BP levels before and after IVT with the following outcomes: 3-month favorable functional outcome (modified Rankin Scale [mRS] scores of 0–1) and 3-month functional independence (mRS scores of 0–2), 3-month mortality and symptomatic intracranial hemorrhage (sICH). Unadjusted analyses of standardized mean differences and adjusted analyses of studies reporting odds ratios (ORadj) per 10 mm Hg BP increment were performed using random-effects models. RESULTS: We identified 26 studies comprising 56,513 patients. Higher pre- (P=0.02) and posttreatment (P=0.006) SBP levels were observed in patients with sICH. Patients with 3-month functional independence had lower post-treatment (P < 0.001) SBP whereas trended towards lower pre-treatment (P=0.06) SBP. In adjusted analyses, elevated pre- (ORadj, 1.08; 95% confidence interval [CI], 1.01 to 1.16) and post-treatment (ORadj, 1.13; 95% CI, 1.01 to 1.25) SBP levels were associated with increased likelihood of sICH. Increasing pre- (ORadj, 0.91; 95% CI, 0.84 to 0.98) and post-treatment (ORadj, 0.70; 95% CI, 0.57 to 0.87) SBP values were also related to lower odds of 3-month functional independence. CONCLUSIONS: We found that elevated BP levels adversely impact AIS outcomes in patients receiving IVT. Future randomized-controlled clinical trials will provide definitive data on the aforementioned association.
Blood Pressure
;
Humans
;
Intracranial Hemorrhages
;
Mortality
;
Odds Ratio
;
Stroke
;
Thrombolytic Therapy